Alvogen Is A Us Based Pharmaceutical Company Founded In 2009 By Ra3Bert Wessmanthe Company Operates With A Lean Structurefocusing On Complex Genericsbiosimilarsand Specialty Pharmaceuticalsparticularly In Emerging Markets Across Europe And Asiaalvogen Builds On The Legacy Of Norwich Pharmaceutical Serviceswhich Has A History Of 130 Years In Manufacturingthe Company Specializes In Research And Developmentglobal Licensingand Market Expansionit Has Over 50 Generic Products Availableincluding Complex Formulations Like Inhalations And Injectablesalvogen Is Also An Early Adopter In Biosimilar Developmenttargeting Treatments For Conditions Such As Autoimmune Diseasescancerand Diabetesits Branded Products Are Marketed Under Almaticawhile Injectable Medications Are Offered Under Almajectalvogen Emphasizes Innovation And Patient Impactfostering A Culture Of Empowerment And Agile Decision Makingthe Company Is Majority Owned By Cvc Capital Partners And Temasek Holdingsand It Continues To Expand Its Reach Through Strategic Partnerships And Acquisitions
